Apligraf denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for apligraf are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies Apligraf on Medical-Necessity Grounds

Cigna's medical-necessity denials for Apligraf almost always come down to one of three documentation deficiencies: the chart does not show that the wound qualifies as a chronic, non-healing ulcer under Cigna's definition; the prior conservative treatment history is incomplete or does not demonstrate an adequate trial before escalating to Apligraf; or the prescribing clinician's notes do not address the specific clinical criteria in Cigna's coverage policy. Because Apligraf is one of the more expensive wound-care interventions, Cigna's review is thorough, and a denial at this stage is common even when the treatment is clinically appropriate.

## Why This Denial Is Appealable

Cigna's coverage policy lists affirmative criteria under which Apligraf is considered medically necessary. If the patient's wound genuinely meets those criteria — chronic non-healing ulcer, adequate prior treatment, documented wound-care specialist involvement — the denial is a documentation problem, not a clinical one. A well-constructed appeal that maps chart facts to each policy criterion, supported by a detailed prescriber letter, is the most effective path to reversal.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): Submit within the timeframe stated on the denial letter (typically 180 days).
• External review: Available through an accredited IRO after final internal denial, generally within four months of that decision.
• Expedited review: Request if wound deterioration poses an imminent risk of limb-threatening complication or hospitalization, with documentation of clinical urgency.

## Concrete Appeal Steps and Timeline

1. Obtain the complete Cigna denial letter and the current Apligraf coverage policy. 2. Identify each medical-necessity criterion in the policy and assess whether the chart documents it. 3. Fill any documentation gaps with an updated wound-care note or prescriber addendum before submitting the appeal. 4. Have the treating wound-care clinician write a medical-necessity letter that addresses every policy criterion by name. 5. Submit the internal appeal with wound photographs, measurement records, prior-treatment history, and the prescriber letter. 6. Request expedited review if wound severity supports it. 7. If denied internally, file for external IRO review immediately.

## Documentation to Gather

• Wound chronicity evidence: Serial photographs and measurements documenting wound duration and size trajectory, with the date care began.
• Prior conservative treatment history: A clear, dated summary of each wound-care modality attempted before Apligraf — debridement, compression therapy, offloading, antimicrobials — and the clinical outcome of each.
• Specialist involvement: Notes from a wound-care specialist, vascular surgeon, podiatrist, or other qualified clinician confirming the treatment plan.
• Diagnosis confirmation: Chart documentation of the specific wound type and any comorbidities that affect healing.
• Prescriber medical-necessity letter: Addresses each of Cigna's stated criteria explicitly and cites the chart evidence that satisfies each one.

## Criteria-Mapping Structure

Copy each requirement from Cigna's coverage policy into a table. In the adjacent column, record the specific chart fact — date, measurement, recorded outcome — that satisfies it. Attach the corresponding chart page as a labeled exhibit for each entry. This one-to-one map is the central piece of a successful medical-necessity appeal and directly mirrors the framework Cigna's clinical reviewers use.